Cortineff

Quick links to important sections

Cortineff

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cortineff

Property Description
Active Ingredient Fludrocortisone Acetate
Form Oral Tablet
Pharmacological Class Synthetic Mineralocorticoid
Common Use Hormone Replacement
Origin Synthetic (Fluorinated derivative)

What is Cortineff and Its Drug Classification?

Cortineff is a prescription medicine containing the synthetic corticosteroid known by its active substance, Fludrocortisone Acetate. It is classified primarily as a highly potent mineralocorticoid, meaning its main physiological role is to act like the natural adrenal hormone, aldosterone. This compound is a synthetic analogue with strong salt-retaining properties.

This medication belongs to the broader category of steroids, yet it is specifically engineered to maximize its mineral-regulating activity. Unlike primary glucocorticoids, which focus heavily on anti-inflammatory effects, Fludrocortisone Acetate possesses a significantly higher and more targeted mineralocorticoid action. It is supplied as an oral tablet for systemic use, offering a consistent route for replacement therapy.


Composition, Origin, and Dosage Form

Cortineff's core therapeutic component is the single active ingredient, Fludrocortisone Acetate.

This compound is synthetic in origin, which guarantees its purity and consistent potency. The structure is a fluorinated derivative of the natural hormone cortisol, a chemical modification that enhances its activity for mineral balance. This unique chemical design relates to its strong regulatory effect on salts and fluids. Cortineff is available solely as a solid-dose oral tablet, a form selected to achieve predictable systemic absorption into the bloodstream.


General Purpose: What Does Fludrocortisone Do?

The general purpose of Fludrocortisone is to sustain the body’s critical mineral and fluid balances, which is essential for maintaining systemic stability.

This action is achieved primarily by regulating the body's electrolytes. The medicine works on the kidneys to promote the retention of sodium (salt) and water while simultaneously increasing the excretion of potassium. By stabilizing the body's salt and fluid levels, the medication helps to manage blood volume and stabilize blood pressure, serving as a component in hormone replacement therapy when the body's natural regulatory systems are deficient.

Regulatory References

  1. Fludrocortisone Acetate Drug Information

What side effects are possible with Cortineff?

Possible Side Effects and Safety Information

The adverse effects of Cortineff (Fludrocortisone Acetate) are primarily related to its potent mineralocorticoid activity, which governs salt and fluid balance, and its systemic corticosteroid properties. Regulatory documents categorize these effects by frequency and the body systems involved.

Documented Adverse Reactions by Frequency

Adverse reactions classified as Very Common (ge 1 in 10 patients) often include Hypertension (high blood pressure), Hypokalaemia (low potassium levels), and Congestive cardiac failure, all linked to the drug's effect on sodium and water retention. Effects such as Muscular weakness and Oedema (swelling) are listed as Common (ge 1 in 100).

Reactions affecting the nervous or psychiatric systems, such as Seizure, Syncope, Delusional perception, or Hallucination, are typically classified as Uncommon (ge 1 in 1,000).

Serious Adverse Reactions and Safety Constraints

Potential serious adverse reactions documented in regulatory labeling include Peptic ulceration (with risk of hemorrhage), Necrotizing angiitis, and the potential for aggravation or masking of existing infections. The use of systemic corticosteroids is also associated with the development of posterior subcapsular cataracts and glaucoma, especially with prolonged use.

Safety documents list specific constraints, such as the contraindication against use in patients with systemic fungal infections. Caution is required when the medicine is used in individuals with pre-existing conditions like renal insufficiency, hypertension, or active peptic ulcer.

Population-Specific Safety Notes

The official label contains specific considerations for certain patient groups. For pediatric patients, long-term administration may result in delayed growth and maturation. In older adults, common adverse effects such as fluid retention and low potassium may be associated with more serious clinical consequences.

Overdose and Emergency Response

Overdose and when to seek help

Overdosage of Cortineff (Fludrocortisone Acetate) is formally documented to present as an exaggeration of its potent mineralocorticoid effects.

Documented Overdose Manifestations
Symptoms include hypertension (high blood pressure), significant edema (fluid retention), and muscular weakness resulting from electrolyte imbalance.
Physiological signs involve excessive potassium loss (hypokalemia) and may include cardiac enlargement.

Overdosage can lead to severe or life-threatening outcomes affecting the physiological systems. Serious clinical outcomes officially listed in regulatory texts include the development of Congestive Heart Failure (CHF) and the severe metabolic disturbance known as Hypokalemic Alkalosis.


Emergency Actions and Management
Immediate Action Required: Contact a Poison Control Center or emergency room at once for any suspected overdose. Emergency services must be contacted if the affected person has collapsed, had a seizure, has trouble breathing, or cannot be awakened.
Supportive Measures: Treatment documented in official sources focuses on correcting the physiological disturbances. This includes the careful monitoring of serum electrolytes and may involve the administration of potassium chloride and restriction of dietary sodium intake. Symptoms typically subside upon dose reduction or discontinuation of the medication.

The regulatory profile is strictly defined by these electrolyte imbalances and cardiovascular complications, which mandate the need for urgent medical assessment and supportive clinical monitoring.

Therapeutic Uses of Cortineff

Quick Facts

  • Used for partial replacement therapy for adrenal hormone insufficiency.
  • Intended to assist in the management of Addison's disease.
  • Employed in the treatment of salt-losing adrenogenital syndrome.

Cortineff (fludrocortisone acetate) serves as a component of replacement therapy for conditions where the adrenal glands do not produce a sufficient amount of certain essential hormones. It is indicated for use in the management of primary and secondary adrenocortical insufficiency, a condition often associated with Addison’s disease. In these contexts, the medication is intended to partially substitute for the missing hormones.

The medication is also utilized in the treatment regimen for salt-losing adrenogenital syndrome, which involves a hormonal imbalance that results in the body losing excessive salt through the urine. Treatment is designed to help address these imbalances.

Regulatory References

  1. DailyMed prescribing information for Fludrocortisone Acetate

Eligibility and Restrictions for Use

Cortineff (Fludrocortisone Acetate) is formally contraindicated and must not be used by individuals with systemic fungal infections or a documented hypersensitivity to any ingredient in the medicine. Use is also contraindicated when taking live or live, attenuated vaccines while on immunosuppressive doses of corticosteroids.

Eligibility is also defined by age and physiological status. The safety and efficacy of Cortineff are not established in pediatric patients; therefore, children on prolonged therapy require close monitoring of growth and development. Older adults must use the medicine with caution due to the greater possibility of decreased hepatic, renal, or cardiac function.

A wide range of existing comorbidities necessitates special caution. These restrictions apply to patients with conditions such as active peptic ulcer, ocular herpes simplex, uncontrolled hypertension, congestive heart failure, tuberculosis, and severe affective disorders. Furthermore, use requires caution in cases of renal insufficiency or hepatic impairment (cirrhosis) due to the potential for enhanced drug effects. For pregnant women, the medicine is classified as Pregnancy Category C, meaning use is restricted to situations where the potential benefit justifies the risk. Caution is advised during lactation.

What should I know about interactions with other medicines?

Cortineff (fludrocortisone acetate) interacts with several medicinal products and substances, primarily by altering the body's exposure to the drug or by compounding specific physiological effects, as documented in official government prescribing information.

Contraindicated Combinations

Co-administration is strictly contraindicated in patients with systemic fungal infections and when receiving live vaccines, based on regulatory guidance.

Alteration of Systemic Exposure

Regulatory documents highlight that the clearance of Cortineff can be modified by concurrent medicines. Substances that induce hepatic enzymes, such as Rifampin, Barbiturates, and Phenytoin, may increase the metabolic clearance of fludrocortisone. Conversely, strong CYP3A inhibitors, including Cobicistat-containing products, are expected to increase systemic exposure and the risk of systemic effects. The use of Estrogen may also increase fludrocortisone levels through altered protein binding.

Pharmacodynamic Effects

Several interactions result in additive physiological outcomes. Co-administration with potassium-depleting diuretics (such as Furosemide) or Amphotericin B enhances the risk of hypokalemia (low potassium). This effect may increase the possibility of toxicity when Digitalis Glycosides are co-administered. The drug may also antagonize the desired effects of anti-hypertensives and anti-diabetic agents. Concurrent use of high-dose Aspirin or other NSAIDs carries an increased risk of gastrointestinal ulceration.

Product Restrictions

Official restrictions state that Cortineff should not be taken with grapefruit juice. Enhanced corticosteroid effects are noted in specific patient populations, including those with hypothyroidism or cirrhosis.

Mechanism of Action

Mineralocorticoid Receptor Activation

Cortineff (Fludrocortisone) is a synthetic steroid that functions as a full agonist for the Mineralocorticoid Receptor (MR) inside target cells, primarily in the renal collecting tubules. Upon binding, the drug-receptor complex translocates to the cell nucleus and acts as a transcription factor, initiating the synthesis of specific transport proteins. This genomic action dictates the cellular changes that follow.

Regulation of Electrolyte Transport and Fluid Volume

The resulting increase in proteins, notably the Epithelial Sodium Channel (ENaC) and the Na^+-K^+-ATPase pump, enhances the active reabsorption of sodium ions (Na^+) from the kidney filtrate back into the bloodstream while promoting the excretion of potassium (K^+). The movement of water that follows the retained sodium contributes to the resulting plasma volume expansion and elevation of systemic blood pressure.

Dynamics of Physiological Constraint

This mechanism exhibits a delayed onset because its action is dependent on gene transcription and new protein synthesis, rather than immediate molecular binding. The mandatory Na^+/K^+ exchange imposes a physiological constraint on the body’s electrolyte balance, which defines the boundaries of the mechanism's influence on ion regulation.

Dosage and Administration Information

How Cortineff is Used

Cortineff (fludrocortisone acetate) is administered by the oral route, available as a tablet or an oral solution, typically in the 0.1 mg strength. Its use follows a standardized protocol established for hormone replacement therapy.


Standard Administration and Dosing

The standard administration schedule for adults is generally a single dose once daily. The usual starting dose for adrenocortical insufficiency is 0.1 mg per day. The total dose is adjusted within a maintenance range of 0.05 mg to 0.2 mg daily, a process known as titration. If temporary hypertension develops, the dose may be reduced to 0.05 mg daily. The medication is generally taken with food or milk to reduce the potential for gastric irritation.

Co-Administration and Use Principles

Fludrocortisone is typically used in conjunction with a glucocorticoid medicine to provide comprehensive replacement therapy. Tablets are often scored to allow for accurate measurement when lower doses are required. For pediatric patients with salt-losing adrenogenital syndrome, typical starting doses range from 0.05 mg to 0.1 mg daily.

A critical principle of use involves anticipating the need for supportive dose increases during periods of physical stress, such as severe illness, surgery, or trauma. If a regular dose is missed, it should be taken as soon as it is remembered, but a double dose must never be taken to make up for the missed timing. This consistent usage pattern defines the long-term protocol for this therapy.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Cortineff


Evidence for Use in Primary and Secondary Adrenocortical Insufficiency

Research explored the role of fludrocortisone acetate in conditions where the adrenal glands do not produce enough natural mineralocorticoid hormones, such as those involved in primary and secondary adrenocortical insufficiency (often associated with Addison’s disease). Research in this area primarily includes long-standing clinical experience, observational studies, and expert consensus guidelines. The nature of this life-critical condition means that large, modern, placebo-controlled trials, which are standard for many new medicines, are limited or unavailable in this context. Withholding mineralocorticoid replacement therapy for research purposes is ethically prohibitive, leading to a reliance on decades of clinical monitoring.

Studies in this context monitored outcomes related to systemic or functional imbalance. Researchers examined how fludrocortisone influences essential body markers, including the serum electrolyte balance (sodium and potassium levels), and the maintenance of blood pressure. Findings from these observational settings describe patterns related to maintaining physiological balance in the observed populations. Research also explored outcomes related to episodic or acute changes.


Evidence for Use in Salt-Losing Adrenogenital Syndrome

Research was also conducted for fludrocortisone's use in managing salt-losing adrenogenital syndrome (also known as salt-wasting Congenital Adrenal Hyperplasia or CAH). This condition was studied for conditions involving periods of heightened symptoms. The evidence structure here also includes clinical experience and consensus guidelines. Studies include retrospective and prospective observational studies.

Studies in these research scenarios monitored outcomes related to outcomes describing episodic or acute changes such as salt-losing crises and also examined the maintenance of sodium and potassium balance. Researchers also examined the necessary requirements for sodium supplementation alongside the medicine.


What is Still Uncertain About Cortineff

Despite its long history of clinical use, certain aspects of fludrocortisone's role and long-term impact are still emerging. Comparative evidence is lacking due to the ethical inability to conduct standard placebo-controlled trials. This means much of the evidence relies on long-term clinical consensus rather than recent head-to-head research. Research also highlights that subgroup findings are uncertain in some areas, such as optimal dosing strategies.

Key Studies & References

  1. DailyMed Label for Fludrocortisone Acetate Tablets (prescribing information)

Frequently Asked Questions (FAQ)

Common questions about Cortineff (FAQ)


Q: How quickly does Cortineff start working after the first dose?

Studies and official information indicate that the drug's biological effects are delayed due to its mechanism of action, which involves stimulating new protein synthesis. While peak concentration in the blood may be reached within an hour or two, the full duration of action, or biological half-life, is prolonged and often noted to be between 18 and 36 hours.


Q: Is it normal to feel more energetic or fatigued when starting Cortineff?

Official labels list unusual tiredness or weakness and severe weakness of arms and legs as possible side effects. These are described as part of a range of undesirable effects that may occur with corticosteroid treatment. Changes in energy levels are generally monitored by a healthcare professional.


Q: Are there any common foods or supplements that interact with Cortineff?

Regulatory documents generally restrict concurrent use of grapefruit juice with this medicine. Due to the drug’s effects on fluid and electrolyte balance, dietary adjustments such as sodium restriction or potassium supplementation are sometimes managed as part of the overall therapy.


Q: Why must blood work often be monitored when taking Cortineff?

Monitoring of blood pressure and serum electrolytes (like sodium and potassium) is essential when taking this medicine. This monitoring helps manage the patient's balance and identify potential issues, such as hypokalemia (low potassium) or hypertension (high blood pressure), which are related to the drug's effects.


Q: Is there a generic version of Cortineff, and how does it compare?

Cortineff contains the active substance Fludrocortisone Acetate, which is widely available as a lower-cost generic tablet. Regulatory and drug information confirms that the active ingredient and its function in the body are the same in both the generic and brand-name versions.


Q: What types of heart conditions are listed as concerns when considering Cortineff?

The official product information notes adverse reactions related to heart and circulation, including hypertension (high blood pressure) and congestive cardiac failure or fluid retention. Official prescribing information requires careful consideration for individuals with pre-existing heart or cardiovascular disease.


Q: Is there a possibility of experiencing mood changes with Cortineff?

Official warnings state that psychic derangements may appear while taking the medicine. These changes can range from mild effects like euphoria, insomnia, and mood swings to more severe reactions. Existing emotional instability may also be aggravated by corticosteroid use.


Q: Is Cortineff a controlled substance or scheduled medication?

Fludrocortisone Acetate is a medicine that requires a prescription for use. However, according to general drug classifications in the United States and Canada, the medicine is not currently listed as a controlled substance or scheduled drug.


Q: Are there any official restrictions on driving or operating machinery while using Cortineff?

Regulatory documents advise that if specific undesirable effects occur, activities like driving or operating machinery should only be performed once the individual knows how the medicine affects them. Potential effects include dizziness, visual disturbances, or fatigue.


Q: Does Cortineff have a Risk Evaluation and Mitigation Strategy (REMS) program?

According to the FDA's regulatory records, a specific Risk Evaluation and Mitigation Strategy (REMS) program has not been required for Fludrocortisone Acetate.


Q: What are the official recommendations regarding alcohol consumption while taking Cortineff?

Official prescribing information states that interactions with individual behavioral risks such as alcohol consumption have not been definitively established through regulatory studies. The primary regulatory documents for the drug itself do not provide established recommendations regarding alcohol consumption.


Q: What is the general patient expectation for follow-up appointments when on Cortineff?

Official prescribing information stresses the importance of regular follow-up visits with a health professional. Follow-up appointments help monitor a patient’s overall condition and detect any potential unwanted effects related to the medicine's impact on electrolytes and blood pressure.


Q: Do medical guidelines mention a maximum treatment duration for Cortineff?

Official documentation does not set a standard maximum treatment duration because this medicine is often used for life-long replacement therapy for chronic conditions. Rather than a time limit, the patient's clinical needs and physiological stress levels determine the adjustments necessary for continued therapy.


Q: Is Cortineff the same kind of drug as prednisone or hydrocortisone?

Cortineff (Fludrocortisone) is in the broader class of corticosteroids, like prednisone and hydrocortisone, but it has a different primary function. Cortineff is primarily a mineralocorticoid, focused on salt and water balance. Prednisone and hydrocortisone are primarily glucocorticoids, which have greater anti-inflammatory effects.


Q: Do people take Cortineff for Addison's disease or low blood pressure?

Official indications confirm that Cortineff is used for partial hormone replacement therapy for adrenal insufficiency, commonly known as Addison's disease. It is also commonly used for managing conditions associated with low blood pressure (orthostatic hypotension), given its role in regulating blood volume and pressure.


Q: How long do the effects of Cortineff last in the body?

The effects are considered prolonged due to the drug's long duration of action. The approximate biological half-life, which reflects how long the drug remains active, is generally reported to be between 18 and 36 hours.


Q: What are the official warnings about stopping Cortineff suddenly?

Official information notes that abrupt cessation of the drug, particularly after long-term use, can be serious and is generally managed through a gradual dose reduction. Potential issues, such as withdrawal symptoms or acute adrenal insufficiency, are reasons why discontinuing the medicine is a process requiring professional management.


Q: Can Cortineff be taken long-term, and what are the general expectations?

The medicine is often used for long-term therapy. Official information suggests that patients on long-term therapy may benefit from carrying medical identification and should be aware that prolonged use may be associated with potential side effects, such as vision changes, that require professional monitoring.


Q: Can people with kidney problems use Cortineff?

Regulatory information indicates that use requires caution in patients with pre-existing renal insufficiency (kidney problems). In cases of severe kidney disease, the medication's effectiveness may be affected, as its primary mechanism of action involves the kidneys.


Q: Does Cortineff cause weight gain, and if so, how is that described?

Yes, weight gain is listed as a possible side effect in official adverse reaction documents. This is related to the drug's mineralocorticoid activity, which causes the retention of sodium and water (fluid build-up) and visible swelling, known as edema.


Q: Can Cortineff be used during pregnancy or while breastfeeding, according to official documents?

The drug is classified as Pregnancy Category C, meaning use is only recommended if the potential benefit is determined to justify the potential risk. Furthermore, official information states that caution is advised during breastfeeding as it is unknown if the medicine is excreted into human milk.


Q: Is Cortineff typically taken alone or with other medications?

Cortineff is often given concomitantly (together) with a glucocorticoid medicine, such as cortisone or hydrocortisone, to provide comprehensive replacement therapy. This combination approach is standard for managing conditions where both mineralocorticoid and glucocorticoid effects are deficient.


Q: How is Cortineff's interaction with antifungal medications generally described?

Regulatory documents state that the medicine is strictly contraindicated (must not be used) in patients with systemic fungal infections. This is a major safety rule due to the risk of aggravating or masking the severity of the existing infection.


Q: How does official prescribing information address the use of Cortineff in patients undergoing surgery?

Official information notes that a supportive dosage (dose adjustment) is often required in times of physical stress, such as surgery, both during the surgical period and for up to a year afterwards. This precaution helps prevent drug-induced adrenal insufficiency when the body is stressed.


Q: Can Cortineff influence blood sugar levels?

Yes, it may influence blood sugar levels. Corticosteroids can reduce the effectiveness of insulin and other anti-diabetic medications. Official information indicates that patients managing diabetes may require adjustments to their existing medication and close monitoring for symptoms of hyperglycemia (high blood sugar).


Q: What is the difference between Cortineff and other steroid treatments?

Cortineff is distinguished by its potent mineralocorticoid activity, meaning its primary effect is on salt and water regulation. Its effects on electrolyte balance are considerably heightened and prolonged when compared to other steroids, which usually have a greater focus on anti-inflammatory action.

How should Cortineff be stored and disposed of?

How to Store and Dispose of Cortineff?

Cortineff (fludrocortisone acetate) tablets must be stored according to specific regulatory requirements to maintain product stability and safety. The medication is typically kept at Controlled Room Temperature (between 20 C and 25 C), protected from excessive heat and moisture.

It is mandatory to store the tablets in their original container, which must be kept tightly closed and light-resistant. This is essential to prevent degradation and maintain the drug's quality until its labeled expiration date.

For safety, the product must be stored out of the sight and reach of children.

When disposing of unused or expired Cortineff, follow official guidance. The tablets should not be thrown away via wastewater or household waste (EU/UK). Instead, utilize a local drug take-back program or consult a pharmacist for environmentally appropriate disposal methods.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cortineff found in:

A-Z Index: